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ABSTRACT 
 
This diploma thesis deals with the selected institutes and specifics of patent law  
in pharmaceutical industry. The aim is to analyze and critically evaluate these institutes 
and specifics. Although the topic requires a certain overlap into different scientific fields, 
the thesis emphasizes on the legal aspects of these institutes. The thesis is based  
on the Czech legislation; however, many chapters require an insight into the European  
or/and international legal context. Furthermore, the case law of a foreign court  
and the European Patent Office is also presented.  
To begin with, the thesis deals with definitions of the key terms of a patent law  
and presents a brief overview of the legislation on the national level as well  
as internationally. In the next chapter the area of pharmaceutical industry is introduced, 
more specifically its historical background and a specific terminology used in such area. 
The thesis contains a chapter dealing with the area of biotechnology as well.  
In the crucial part of this thesis, firstly general requirements for patentability  
of inventions are defined and the question of patentability of biotechnological inventions  
is evaluated. The attitude towards patentability of genetic modifications and cloning  
is evaluated more closely. Furthermore the requirements of the gene´s patentability  
are analyzed in the European context and compered to legal regulation  
in the U.S. The thesis provides an evaluation of current legislation in a conclusion  
of this chapter. The regulation of an invention belonging to an enterprise and a joint 
proprietorship of a patent is introduced in the following parts of the thesis. To provide  
a complex overview, the effects of the patent are analyzed as well and the topic  
of limitation of effects of patent follows. Moreover, it examines the institute  
of a compulsory license. The thesis offers examples of its granting across several 
jurisdictions and provides a critical analysis of how this institute is being used.  
In the concluding part the thesis deals with a question of a term of the patent  
and introduces a regulation of an institute specific for the area  
of pharmaceuticals - a supplementary protection certificate.   
 
